India-made iNCOVACC, world's first intra-nasal vaccine to receive approval for both primary series, Heterologous booster
Nov 28, 2022
iNCOVACC, on Tuesday, became the world's first intra-nasal vaccine to receive both Primary series and Heterologous booster approval, Bharat Biotech International Limited (BBIL) announced